TOKYO -- Keio University is joining hands with Cyberdyne to develop treatments for spinal cord injuries that combine induced pluripotent stem cell therapy with the startup's wearable cybersuit.
Cyberdyne's HAL for Medical Use robotic suit will be used to treat spinal-cord injuries.
The project will proceed in two stages starting this year, with the two parties entering into a partnership agreement Monday.
